Disclaimer

This service is solely for personal and non-commercial use and general information and reference only. This information is strictly prohibited for distributing or made available to any person. The information in this website relating to funds is provided by Morningstar Asia Limited (“Information Provider”) to Chief Securities Limited (the "Company") unless otherwise specified. For technical reasons, certain information provided by Information Provider may be different from that supplied by the respective fund houses. Neither the Information Provider nor the Company guarantee or endorse the accuracy, reliability and completeness of the information provided by the Information Provider or that it is up-to-date, and that such information has not been independently verified by the Company. The Company disclaims liability for any errors, omissions, or inaccuracies in the information provided in this website. The Company also disclaims liability for any loss or damages resulting from the use of the information contained herein, or the inability to use such information or in connection with any error, interruption, delay in operation or incomplete transmission, line or system failure.

For information which is "Powered By" the Information Provider and other fund houses, it is being re-transmitted by the Company in the ordinary course of business to you for general information and reference purposes only.

This service should not be regarded as an offer, solicitation, or recommendation to buy or sell investment products in any jurisdiction to any person to whom it is unlawful to make such an invitation, offer, solicitation or recommendation in such jurisdictions.

The relevant pages for funds have not been reviewed by the Securities and Futures Commission in Hong Kong ("SFC"). The information contained herein is for general information and reference purposes only and is not intended to provide professional investment or other advice. It is not intended to form the basis of any investment decision. Persons accessing this website should not make any investment decision based solely on the information and services provided herein. Before making any investment decision, persons accessing this website should take into account his/her own circumstances including but not limited to his/her financial situation, investment experience, and investment objectives, and should understand the nature, terms and risks of the relevant funds. Persons accessing these pages should obtain appropriate professional advice where necessary.

Investors should note that all investments involve risks (including the possibility of a loss of the capital invested), prices of funds may go up as well as down and past performance information presented is not necessarily a guide to the future performance. Investors should read the relevant fund’s offering documents (including the stated full text of the risk factors) and seek independent financial advice before making any investment decision. Smaller or emerging markets for funds can be more volatile than developed markets and can carry more risk. Independent financial advice should be taken before entering into any financial transaction. The information, contents and/ or features of the webpages are subject to change without notice.

Disclaimer
Important message to readers and internet privacy policy statement
Copyright © 2024 Chief Group Limited. All rights reserved.

Provide Chinese Only.

每月動向

2022年1月基金投資動向

2021年12月31日

去年主要地區股市表現不一,美國股市造好,中國股市表現平穩。經濟雖然錄得正面增長,但整體通脹上升,市場擔心「收水」及利率趨升。2022年基金投資策略,經濟復甦仍為重要主題

新的一年開始了,踏入2022年,祝大家新年進步,身體健康!

去年主要地區股市表現不一,年內市場波動很大。隨著全球疫苗接種率上升,社區逐步重啟,經濟雖然錄得正面增長,但整體通脹上升,市場擔心「收水」及利率趨升;疫情蔓延亦因變種病毒而出現反覆,繼Delta 之後又出現Omicron,各國正嚴陣以待,加強社區封鎖措施。變種病毒傳染性雖強,但若重症及死亡率不高或在可控制範圍之內,則經濟復甦仍將會是2022年之重要主題。

2021年美國股市造好。截至12月30日,道指、標指、納指年內累計上升,其中標指由年初起計升幅更達27.23%。受惠於經濟復甦,傳統週期性股份表現不俗,資源股、金融股、消費行業等基金,應可繼續留意。至於通脹會否加速利率上升而不利新經濟股之表現,則要視乎加息幅度是否市場預期之內。建議投資者宜注視分散資產配置,平衡風險回報。

中國股市表現平穩,其中上証綜合指數全年(截至12月30日)累升4.21%。內地去年推出多項行業監管措施、內房股資金鏈出現缺口,加上美國對中概股之限制等,影響香港股市下跌,恒生指數、恒生科指分別累計跌幅(截至12 月30日)達15.13%、35.01%。來年寄望中概股回歸帶動整體股市成交額回升;而預期內地將陸續推出刺激經濟政策,包括降準、減息、減稅等,將有利吸引外資買入中港股票。倘變種病毒影響有限,則中港通關在望,香港零售消費行業能夠受惠。

中美關係緊張,貿易聯繫受到影響,部分生產及貿易因此而轉往其他國家或地區,其中印度、台灣、越南等之經濟及股市表現不俗,個別基金去年表現上升超過30%。

2022年基金投資策略,經濟復甦仍為重要主題,傳統經濟之股票基金應可繼續受惠;倘疫情進一步受控,在多國加大基建項目投資下,將刺激需求,資源股份類別之基金值得留意。利率上升,金融基金亦可考慮。

地區方面,美國股市去年屢創新高,市場流動性仍然充裕,股市續有支持,不過,市場仍然密切注視美國通脹及利率,會否令美聯儲加快加息步伐。從價值概念上,中港股票或會受惠,外資近期流入 A股似有上升跡象。整體而言,建議大家分散投資,勿太過集中單一地區;分配權重方面,亞洲或可考慮配置多一點。

客戶如欲查詢有關基金資訊,歡迎致電致富理財熱線: 2500 9188 聯絡我們。

開戶尊享 HK$300 獎賞優惠

由即日起,親臨致富理財中心或於網上開戶並輸入推廣碼 US099,只需符合相關條件,可享HK$300 Donki禮券!推薦親朋好友開戶,可以獲取高達HK$6,000禮券*!了解更多

投資基金「零」負擔

透過「致富通」應用程式或致富網頁,投資基金「零」負擔,單次認購或月供計劃一律免佣,基金購金額更低至5,000港元或700美元,另購買精選保險享有高達50%折扣優惠。

致富有提供債券、基金一站式投資策略,比供客戶選擇。想知道和了解更多,請即刻聯絡我哋們投資策略專員解答疑難!

WhatsApp : 投資策略專員

更多基金資訊、種類 和 比較:

連結

投資涉及風險,以上建議只作為參考之用。致富在法律上均不負責任何人因使用本報告內資料而蒙受的任何直接或間接損失。以上報告由致富集團研究部的分析員(“此等人士”)所撰寫,此等人士均為香港證監會持牌人士。此外,截至本報告發表當日,此等人士均未於本報告中所推介的股份存有權益。



免責聲明
上述報告由致富證券有限公司(「本公司」)所提供,所載之內容或意見乃根據本公司認為可靠之資料來源來編製,惟本公司並不就此等內容之準確性、完整性及正確性作出明示或默示之保證。上述報告內之所有意見均可在不作另行通知之下作出更改。上述報告的作用純粹為提供資訊,並不應視為對上述報告內提及的任何產品買賣或交易之專業推介、建議、邀請或要約。本公司及其附屬公司、僱員及其家屬及有關人士可於任何時間持有、買賣或以市場認可之方式,包括以代理人或當事人對本報告內提及的任何產品進行投資或買賣。投資附帶風險,投資者需注意投資項目之價值可升亦可跌,而過往之表現亦不一定反映未來之表現。投資者進行投資前請尋求獨立之投資意見。本公司在法律上均不負責任何人因使用本報告內資料而蒙受的任何直接或間接損失。本公司擁有此報告內容之版權,在未獲本公司許可前,不得翻印、分發或發行本報告以作任何用途。

< 返回致富研究
App Download
Instant trading of stocks after taking an in-depth look at every move of the market
Website Push Notifications
Provide the latest financial news and promotions

Subscribe to keep up to date with CHIEF
Informative contents include:
Latest news, coming seminar, featured articles on wealth management